By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Rheonix has closed on a $6 million extension to its Series A financing round, bringing the total raised in the round to $18.6 million.

Tony Eisenhut, the firm's president, told GenomeWeb Daily News today that the funds will be used to continue developing four tests: a warfarin-sensitivity test; a sexually transmitted disease panel; an HIV panel; and a CYP2C19 test for predicting response to the anti-platelet drug Plavix (clopidogrel).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: Leukemia-like disease in soft-shell clams, mNET-seq method for profiling growing transcripts, and more.

While James Watson and Francis Crick are credited for discovering the structure of DNA, Rich proved their theory of a double helix structure was correct when he produced a distinct image of the structure.

Nature News reports that early users of Oxford Nanopore's hand-held MinIon are giddy about the technology and its uses. 

According to MIT Technology Review, Apple is collaborating with researchers to develop apps for consumer DNA testing.